Status:
COMPLETED
Anxiety Sensitivity Treatment for Heroin Users
Lead Sponsor:
University of Maryland, College Park
Conditions:
Anxiety
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving tre...
Eligibility Criteria
Inclusion
- exhibit a score of 21 on a self-report measure of anxiety sensitivity
- be in 28 days of residential substance use treatment.
- meet criteria for current opioid dependence as determined by SCID interview administered at intake.
Exclusion
- evidence of limited mental competency
- the inability to give informed, voluntary, written consent to participate
- current psychosis
- current bipolar disorder.
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01196312
Start Date
October 1 2009
End Date
September 1 2011
Last Update
May 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Salvation Army Harbor Light Treatment Facilitiy
Washington D.C., District of Columbia, United States, 20002